Day: August 27, 2021

ISEI’s 21st congress to discuss economic recovery acceleration

Indonesia’s Economic Bachelors Association (ISEI) will hold its 21st congress and national seminar entitled ‘ISEI’s Role in Strengthening Synergy to Expedite National Economic Recovery in the Digital Age’ on August 31, 2021. “There will be three blocks, one is the role of ISEI, (two is the) economic recovery process, and

Bank Indonesia sees inflation at 0.01% in August

Bank Indonesia has forecast 0.01 percent monthly inflation in August 2021 in view of the price development of cooking oil, tomato, chicken egg, and cigarette. “With that development, the year-to-date inflation is projected to be around 0.82 percent while the year-on-year inflation will be around 1.57 percent for August 2021,”

Deputy Governor sees face-to-face class in all schools by January 2022

Deputy Governor of Jakarta, Ahmad Riza Patria, has said he expects all schools in the capital to restart face-to-face learning (PTM) activities from January 2022. “PTM will gradually begin and schools will reopen, I expect that all schools in Jakarta will perform face-to-face learning by January (next year),” Patria said

Minister Pandjaitan inaugurates Yogyakarta Airport Railway services

Coordinating Minister for Maritime Affairs and Investment, Luhut Binsar Pandjaitan, has inaugurated operations at the Yogyakarta International Airport’s Railway on Friday. Construction work on the project had begun in 2015. The project fell under the national strategic projects list and its investment is valued at 1.1 trillion Indonesian rupiahs. “I

Indonesia receives 6.08 million doses of COVID vaccine

Indonesia on Friday received 6.086  million additional COVID-19 vaccines, comprising 5 million doses from Sinova in the form of finished products and 1.086 million  doses from AstraZeneca, though a direct purchase scheme. “With the arrival of the vaccines, it means that Indonesia has received 208.7 million doses of COVID-19 vaccine,” Bio Farma’s

Junshi Biosciences Announces Acceptance by NMPA of Investigational New Drug Application for the Subcutaneous Injection of Anti-BLyS Monoclonal Antibody

SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted an investigational new drug application for UBP1213sc, its